ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins

Advanced Drug Delivery Reviews

Volumn 54, Issue 1, 2002, Pages 99-134

  Kissel, Thomas ^a   Li, Youxin ^b   Unger, Florian ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Schwarz Pharma AG   (Germany)

Author keywords

ABA triblock copolymers; Biocompatibility; Biodegradable hydrogels; Biodegradation; Characterization; Polyester polyether block copolymers; Protein delivery systems; Synthesis

Indexed keywords

DEGRADATION; DIFFUSION; DNA; HYDROGELS; POLYESTERS; PROTEINS;

DRUG DELIVERY DEVICES;

COPOLYMERS;

COPOLYMER; LACTONE; MACROGOL; MICROSPHERE; NANOPARTICLE; POLYESTER; POLYGLACTIN; PROTEIN;

BIOCOMPATIBILITY; BIODEGRADATION; CRYSTALLIZATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HYDROGEL; HYDROPHILICITY; IMPLANT; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW;

EID: 0037122783     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00244-7     Document Type: Article

References (112)

1. Custom-made biomaterials
2. Biodegradable polymers for use in surgery - Poly(ethylene oxide) poly(ethylene terephthalate) (PEO/PET) copolymers:1
3. Morphological study of biodegradable PEO/PLA block copolymers
4. Synthesis, characterization and hydrolytic degradation of PLA/PEO/PLA copolymers with long poly(L-lactic acid) chains
5. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
6. Long circulating microparticulate carriers
7. In-vitro degradation and bovine serum albumine release of the ABA triblock copolymers consisting of poly(L(+)lactic acid), or poly(L(+)lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks
8. Synthese et caracterisation de copolymeres sequences polyoxyethylene/poly-ε-caprolactone
9. Polyether-polyester block copolymers by non-catalysed polymerization of ε-caprolactone with poly(ethylene glycol)
10. Synthesis and characterization of polymers from β-propiolactone and poly(ethylene glycol)s
11. Design and synthesis of biodegradable poly(ether-esters)
12. Biodegradable PELA block copolymers: In vitro degradation and tissue reaction
13. Synthesis and characterization of block copolymers from D,L-lactide and poly(ethylene glycol) with stannous chloride
14. ABA triblock copolymers of L-lactide and poly(ethylene glycol)
15. Structural analysis and degradation behavior in polyethylene glycol/poly(L-lactide) copolymers
16. Mechanism of lactide polymerization in the presence of stannous octoate: The effect of hydroxy and carboxylic acid substances
17. Hydrogels of poly(ethylene glycol)-copoly(lactones) diacrylate macromers and beta-chitin
18. Microdomain structure in polylactide-block-poly(ethylene oxide) copolymer films
19. Synthesis and thermal behavior of triblock copolymers from L-lactide and ethylene glycol with long center PEG block
20. Preparation and characterization of polylactide-poly(ethylene glycol)-polylactide triblock polymers and a preliminary in vivo examination of the blood circulation time for the nanoparticles made therefrom
21. Synthesis and characterization of novel ABA triblock copolymers from L-lactide, glycolide, and PEG
22. Stereocomplex formation in ABA triblock copolymers of poly(lactide) (A) and poly(ethylene glycol) (B)
23. ABA type copolymers of lactide with poly(ethylene glycol). Kinetic, mechanistic, and model studies
24. Biodegradable poly(ethylene glycol)-poly(L-lactide block copolymers
25. Properties of block- and random-copolymers of lactic acid and glycolic acid
26. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly (L-lactic acid) or poly (L-lactic-co-glycolic acid) A-blocks attached to central poly (oxyethylene) B-blocks
27. Studies on the block copolymerization of D,L-lactide and polyethylene glycol with aluminum complex catalyst
28. Synthesis, characteristics and in vitro degradation of star-block copolymers consisting of L-lactide, glycolide and branched multi-arm poly(ethylene oxide)
29. Kinetics and mechanism of L-lactide polymerization using two different yttrium alkoxides as initiators
30. A versatile and highly efficient catalyst system for the preparation of polyesters based on lanthanide tris(2,6-di-tert-butylphenolate)s and various alcohols
31. 2
32. Lithium chloride as catalyst for the ring-opening polymerization of lactide in the presence of hydroxyl-containing compounds
33. Block copolymers from L-lactide and polyethylene glycol through a non-catalyzed route
34. Polymerization of lactones. 17. Synthesis of ethylene glycol-L-lactide block copolymers
35. Polylactones. Anionic polymerization of L-lactide. Variation of end groups and synthesis of block copolymers with poly (ethylene oxide)
36. Thermoplastic biodegradable hydrogels: Star-shaped block copolymer for polypeptide drug delivery
37. Thermal behaviour of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) triblock copolymers
38. Poly-DL-lactic acid: Polyethylene glycol block copolymers. The influence of polyethylene glycol on the degradation of poly-DL-lactic acid
39. Compositional and structural analysis of PELA biodegradable block copolymers degrading under in vitro conditions
40. Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media. Part III: Influence of the morphology of poly(L-lactic acid), PLA 100
41. Synthesis, characterization and hydrolytic degradation of PLA/PEO/PLA copolymers with short poly(L-lactic acid) chains
42. Block copolymers of L-lactide and poly(ethylene glycol) for biomedical applications
43. The biodegradation of poly(ester-ether-ester) block copolymers in a cellular environment in vitro
44. The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly(lactide-co-glycolide) and ABA triblock copolymers
45. Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: Influence of buffer media on polymer erosion and bovine serum albumin release
46. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: Is the erosion controlled by degradation, swelling or diffusion?
47. Structure-property relationships in the case of the degradation of solid aliphatic poly(α-hydroxy acids) in aqueous media. I: Poly(D,L-lactic acid) or PLA 50
48. Structure-property relationships in the case of the degradation of massive poly(α-hydroxy acids) in aqueous media. II: Degradation of lactide/glycolide copolymers: PLA37.5GA25 and PLA75GA25
49. More about the degradation of LA/GA-derived matrices in aqueous media
50. Effect of soft segment on degradation kinetics in polyethylene glycol/poly(L-lactide) block copolymers
51. Poly(ester-ether-ester) block copolymers as biomaterials
52. Degradation products of poly(ester-ether-ester) block copolymers do not alter endothelial metabolism in vitro
53. Biocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models
54. In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks
55. Biocompatibility of ABA triblock copolymer microparticles consisting of poly(L-lactic-co-glycolic-acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection
56. Polymeric systems for controlled drug release
57. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
58. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems
59. Poly(lactide-co-glykolide) microparticles for the development of single-dose controlled-release vaccines
60. Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate
61. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
62. Parenteral depot-systems on the basis of biodegradable polyesters
63. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability
64. Drug delivery systems and routes of administration of peptide and protein drugs
65. New long-acting injectable microcapsule contraceptive system
66. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence
67. Biodegradation of PLA/GA polymers: Increasing complexity
68. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres
69. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks
70. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation
71. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues
72. Protein instability in poly(lactic-co-glycolic acid) microparticles
73. Swelling-controlled, constant rate delivery systems
74. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release
75. Hydrogels for controlled drug delivery
76. Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study
77. The release of 5-fluorouracil from a swellable matrix of a triblock copolymer of epsilon-caprolactone and ethylene-oxide
78. Block copolymers of L-lactide and poly(ethylene glycol) as potential drug-releasing materials: A preliminary investigation
79. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein
80. Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein
81. New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers
82. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone
83. A biodegradable polymer as a cytokine delivery system for inducing bone formation
84. Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type
85. Biodegradable block copolymer matrices for long-acting contraceptives with constant release
86. Release properties of macromolecules from microspheres of a ABA triblock copolymer consisting of poly(lactic-co-glycolic acid) and polyoxyethylene
87. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks
88. Drug release from PLA/PEG microparticulates
89. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO- LPLG triblock copolymers: Protein stabilization and in-vitro release properties
90. Branched biodegradable polyesters for parenteral drug delivery systems
91. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: Influence of encapsulation technique and polymer composition on particle characteristics
92. Microencapsulation of antigens using biodegradable polyesters: Facts and phantasies
93. Biodegradable microspheres containing influenza A vaccine: Immune response in mice
94. Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira interrogans antigens
95. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped Vibrio cholera antigens
96. In vitro protein release and degradation of poly-DL-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: Quantitative evaluation of factors involved in protein release
97. Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(L-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo
98. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro
99. Cellular uptake of PEO surface-modified nanoparticles: Evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers
100. Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles
101. Drug transport in and release from controlled delivery devices of hydrophilic/hydrophobic block and graft copolymers
102. Polymer-polymer phase behavior
103. Predicting controlled-release behavior of degradable PLA-b-PEG-b-PLA hydrogels
104. XPS and SSIMS analysis revealing surface segregation and short-range order in solid films of block copolymers of PEO and PLGA
105. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition
106. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): Protein stability and the effect of stabilizing excipients
107. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: Mechanisms of stabilization by basic additives
108. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide)
109. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives
110. Introduction to biotechnical and biomedical applications of poly(ethylene glycol)